Sensafex 180 Mg 180 mg FC tablets
PDF Leaflet Revision Date: 3 September 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with chronic idiopathic urticaria.
Dosage (summary)
One 180 mg tablet daily for adults and children aged 12 years and over.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Erythromycin
- Ketoconazole
- Antacids containing aluminium and magnesium
Contraindications
- Hypersensitivity to fexofenadine or excipients
Common side effects
- Headache
- Drowsiness
- Dizziness
- Nausea
Counselling Points
- Take orally with liquid, do not chew or break tablets.
- Avoid alcohol and CNS depressants.
Serious warnings
- Use with caution in patients with cardiovascular disease
Important Disclaimer
The Sensafex 180 Mg 180 mg FC tablets professional information leaflet below is the property of Oethmaan Biosims and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
